KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,972,247 | -39.5% | 1,868,507 | 0.0% | 1.24% | -25.0% |
| Q2 2023 | $42,956,976 | -39.9% | 1,868,507 | -22.5% | 1.65% | -46.8% |
| Q1 2023 | $71,431,085 | +7.0% | 2,410,769 | -9.8% | 3.10% | +13.5% |
| Q4 2022 | $66,738,972 | +6.6% | 2,673,837 | -7.0% | 2.73% | +12.4% |
| Q3 2022 | $62,624,000 | +22.0% | 2,876,637 | +10.3% | 2.43% | +23.9% |
| Q2 2022 | $51,334,000 | -53.6% | 2,607,130 | -0.3% | 1.96% | -43.3% |
| Q1 2022 | $110,668,000 | -32.6% | 2,615,030 | +1.1% | 3.46% | -7.5% |
| Q4 2021 | $164,295,000 | +0.1% | 2,587,730 | -7.4% | 3.74% | +30.5% |
| Q3 2021 | $164,102,000 | +33.7% | 2,793,708 | +10.4% | 2.86% | +57.5% |
| Q2 2021 | $122,778,000 | +21.4% | 2,531,508 | -2.8% | 1.82% | +27.5% |
| Q1 2021 | $101,158,000 | -40.0% | 2,603,139 | -4.3% | 1.42% | -30.2% |
| Q4 2020 | $168,670,000 | +91.0% | 2,720,489 | -0.4% | 2.04% | +26.0% |
| Q3 2020 | $88,292,000 | – | 2,732,660 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |